Company profile

Monte Rosa Therapeutics

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (M

Industry
Biotechnology Research
Employees
223
Headquarters
Boston, Massachusetts
LinkedIn followers
34,946
Office locations
2

Monte Rosa Therapeutics company summary

Monte Rosa Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts. On LinkedIn the company has around 223 employees and 34,946 followers. The company lists 2 office locations.

What technology does Monte Rosa Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Monte Rosa Therapeutics

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.

Where is Monte Rosa Therapeutics located?

Monte Rosa Therapeutics lists 2 office locations.

Boston, Massachusetts, USHQ
321 Harrison Ave
Basel, 4057, CH
Klybeckstrasse 191

Compare companies similar to Monte Rosa Therapeutics

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Monte Rosa Therapeutics
monterosatx.com
Biotechnology Research223-Boston, Massachusetts
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Monte Rosa Therapeutics

What does Monte Rosa Therapeutics do?

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.

How many employees does Monte Rosa Therapeutics have?

Monte Rosa Therapeutics has around 223 employees on LinkedIn.

Where is Monte Rosa Therapeutics headquartered?

Monte Rosa Therapeutics is headquartered in Boston, Massachusetts.

Where does Monte Rosa Therapeutics have offices?

Monte Rosa Therapeutics lists 2 office locations, including Boston, Massachusetts, US; Basel, 4057, CH.

Build a lead list from companies like Monte Rosa Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.